Portrait of Dana Larsen
ucsf logo

Dana Larsen, MD

Nephrology
Kidney Disease (Nephrology) Parnassus
415-353-2507
Portrait of Dana Larsen
Portrait of Dana Larsen
ucsf logo

Dana Larsen, MD

Nephrology
Kidney Disease (Nephrology) Parnassus
415-353-2507

On this page

Education & training

Board certification

  • Nephrology, American Board of Internal Medicine/Nephrology
  • Internal Medicine, American Board of Internal Medicine

Fellowship

  • Nephrology, University of CA at San Francisco - Urology GME

Residency

  • Internal Medicine, Massachusetts General Hospital GME

Internship

  • Internal Medicine, Massachusetts General Hospital GME

Degree

  • MD, Baylor College of Medicine

My expertise

  • Specialties
    • Nephrology

Locations

    Reviews

    Average rating

    5
    5 out of 5 Stars
    64 ratings
    About provider reviews

    Showing 1-6 of 9 reviews

    Sort by
    • 5 out of 5 Stars
      January 28, 2026

      Perfect experience Dr. Larsen rates A plus

    • 4.9 out of 5 Stars
      August 20, 2025

      Dr. Larsen is friendly, clear in her discussion, helpful in understanding my issues and gives excellent advice.

    • 5 out of 5 Stars
      May 29, 2025

      Dr. Larsen is an outstanding doctor!

    • 5 out of 5 Stars
      March 23, 2025

      Very professional . Took the time to learn about my history and plan for my followup treatment.

    • 5 out of 5 Stars
      October 22, 2024

      When ever I'm with my doctor they always listen to what's going on

    • 5 out of 5 Stars
      August 5, 2024

      Very easy to talk with

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.